Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From what I have read many do not believe we getting payments..

Shareholders are led to believe that TPL is only pursuing one time payments. If this has changed in any way, then I believe it is the responsibility of our BOD's to inform the shareholders that other methods of collecting licence fees other than one time payments is being pursued.

Steve

Share
New Message
Please login to post a reply